PELI2 is a negative regulator of STING signaling that is dynamically repressed during viral infection
Molecular Cell · 2024
DOI: 10.1016/j.molcel.2024.06.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2024. Verfasst von Christopher Ritchie und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Stanford University, Stanford, CA 94305, USA; Sarafan ChEM-H Institute, Stanford University, Stanford, CA 94305, USA; Arc…. Hauptthemen laut MEDLINE: Signal Transduction, Protein Serine-Threonine Kinases, Membrane Proteins, Interferon Regulatory Factor-3. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The innate immune cGAS-STING pathway is activated by cytosolic double-stranded DNA (dsDNA), a ubiquitous danger signal, to produce interferon, a potent anti-viral and anti-cancer cytokine. However, STING activation must be tightly controlled because aberrant interferon production leads to debilitating interferonopathies. Here, we discover PELI2 as a crucial negative regulator of STING. Mechanistically, PELI2 inhibits the transcription factor IRF3 by binding to phosphorylated Thr354 and Thr356 on the C-terminal tail of STING, leading to ubiquitination and inhibition of the kinase TBK1. PELI2 sets a threshold for STING activation that tolerates low levels of cytosolic dsDNA, such as that caused by silenced TREX1, RNASEH2B, BRCA1, or SETX. When this threshold is reached, such as during viral infection, STING-induced interferon production temporarily downregulates PELI2, creating a positive feedback loop allowing a robust immune response. Lupus patients have insufficient PELI2 levels and high basal interferon production, suggesting that PELI2 dysregulation may drive the onset of lupus and other interferonopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Stanford University, Stanford, CA 94305, USA; Sarafan ChEM-H Institute, Stanford University, Stanford, CA 94305, USA; Arc Institute, Palo Alto, CA 94304, USA. Electronic address: chrisr@arcin…
- Department of Biochemistry, Stanford University, Stanford, CA 94305, USA; Sarafan ChEM-H Institute, Stanford University, Stanford, CA 94305, USA; Arc Institute, Palo Alto, CA 94304, USA. Electronic address: lingyin@arci…
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Ritchie, C., & Li, L. (2024). PELI2 is a negative regulator of STING signaling that is dynamically repressed during viral infection. Molecular Cell. https://doi.org/10.1016/j.molcel.2024.06.001
Vancouver
Ritchie C, Li L. PELI2 is a negative regulator of STING signaling that is dynamically repressed during viral infection. Molecular Cell. 2024. doi:10.1016/j.molcel.2024.06.001
BibTeX
@article{Ritchie2024,
author = {Ritchie, Christopher and Li, Lingyin},
title = {PELI2 is a negative regulator of STING signaling that is dynamically repressed during viral infection},
journal = {Molecular Cell},
year = {2024},
doi = {10.1016/j.molcel.2024.06.001}
}
EUVIMED